Lower levels of prepulse inhibition in luteal phase cycling women in comparison with postmenopausal women

Psychoneuroendocrinology

Volumn 35, Issue 3, 2010, Pages 422-429

  Bannbers, Elin ^a   Kask, Kristiina ^a   Wikström, Johan ^a   Sundström Poromaa, Inger ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Estradiol; Hormone replacement therapy; Menopause; Prepulse inhibition; Progesterone; Startle response

Indexed keywords

ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; ESTRADIOL BLOOD LEVEL; EVOKED AUDITORY RESPONSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MENSTRUATION; NORMAL HUMAN; POSTMENOPAUSE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ESTRADIOL; FEMALE; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; MIDDLE AGED; NEURAL INHIBITION; POSTMENOPAUSE; PROGESTERONE; STARTLE REACTION; TIME FACTORS; YOUNG ADULT;

EID: 77649275296     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.08.004     Document Type: Article

References (36)

1. Aasen I., Kolli L., Kumari V. Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J. Psychopharmacol. 2005, 19:39-45.
2. Blumenthal T.D. Prepulse inhibition decreases as startle reactivity habituates. Psychophysiology 1997, 34:446-450.
3. Blumenthal T.D., Cuthbert B.N., Filion D.L., Hackley S., Lipp O.V., van Boxtel A. Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 2005, 42:1-15.
4. Borgstrom A., Kask K., Gulinello M., Odlind V., Sundström Poromaa I. Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology 2008, 33:487-496.
5. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl.) 2001, 156:234-258.
6. Cadenhead K.S., Carasso B.S., Swerdlow N.R., Geyer M.A., Braff D.L. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol. Psychiatry 1999, 45:360-364.
7. Davis M. Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes. Neurosci. Biobehav. Rev. 1980, 4:241-263.
8. Ellwanger J., Geyer M.A., Braff D.L. The relationship of age to prepulse inhibition and habituation of the acoustic startle response. Biol. Psychol. 2003, 62:175-195.
9. Frey B.N., Lord C., Soares C.N. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause Int. 2008, 14:123-128.
10. Gogos A., Nathan P.J., Guille V., Croft R.J., van den Buuse M. Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 2006, 31:885-889.
11. Gogos A., Van den Buuse M. Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J. Pharmacol. Exp. Ther. 2004, 309:267-274.
12. Grillon C. Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol. Psychiatry 2002, 52:958-975.
13. Hafner H., Maurer K., Loffler W., Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br. J. Psychiatry 1993, 162:80-86.
14. Herrington D.M., Vittinghoff E., Lin F., Fong J., Harris F., Hunninghake D., Bittner V., Schrott H.G., Blumenthal R.S., Levy R. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002, 105:2962-2967.
15. Hoenig K., Hochrein A., Quednow B.B., Maier W., Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol. Psychiatry 2005, 57:1153-1158.
16. Jovanovic T., Szilagyi S., Chakravorty S., Fiallos A.M., Lewison B.J., Parwani A., Schwartz M.P., Gonzenbach S., Rotrosen J.P., Duncan E.J. Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 2004, 41:401-406.
17. Kask K., Backstrom T., Gulinello M., Sundström Poromaa I. Lower levels of prepulse inhibition of startle response in pregnant women compared to postpartum women. Psychoneuroendocrinology 2008, 33:100-107.
18. Kask K., Backstrom T., Lundgren P., Sundström Poromaa I. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls. Pharmacol. Biochem. Behav. 2009, 92:608-613.
19. Kask K., Gulinello M., Backstrom T., Geyer M.A., Sundström Poromaa I. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 2008, 33:2283-2290.
20. Koch M. Sensorimotor gating changes across the estrous cycle in female rats. Physiol. Behav. 1998, 64:625-628.
21. Kumari V., Aasen I., Papadopoulos A., Bojang F., Poon L., Halari R., Cleare A.J. A comparison of prepulse inhibition in pre- and postmenopausal women and age-matched men. Neuropsychopharmacology 2008, 23:23.
22. Kumari V., Aasen I., Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr. Res. 2004, 69:219-235.
23. Ludewig K., Ludewig S., Seitz A., Obrist M., Geyer M.A., Vollenweider F.X. The acoustic startle reflex and its modulation: effects of age and gender in humans. Biol. Psychol. 2003, 63:311-323.
24. Ludewig S., Ludewig K., Geyer M.A., Hell D., Vollenweider F.X. Prepulse inhibition deficits in patients with panic disorder. Depress. Anxiety 2002, 15:55-60.
25. McEwen B.S., Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 1999, 20:279-307.
26. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
27. Osterlund M.K., Hurd Y.L. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog. Neurobiol. 2001, 64:251-267.
28. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
29. Rupprecht R., Koch M., Montkowski A., Lancel M., Faulhaber J., Harting J., Spanagel R. Assessment of neuroleptic-like properties of progesterone. Psychopharmacology (Berl.) 1999, 143:29-38.
30. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57.
31. Sundström I., Spigset O., Andersson A., Appelblad P., Backstrom T. Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics. Eur. J. Clin. Pharmacol. 1999, 55:125-130.
32. Swerdlow N.R., Auerbach P., Monroe S.M., Hartston H., Geyer M.A., Braff D.L. Men are more inhibited than women by weak prepulses. Biol. Psychiatry 1993, 34:253-260.
33. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl.) 2001, 156:194-215.
34. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol. Psychiatry 1997, 41:452-460.
35. Swerdlow N.R., Light G.A., Cadenhead K.S., Sprock J., Hsieh M.H., Braff D.L. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch. Gen. Psychiatry 2006, 63:1325-1335.
36. World Health Organization, WHO Scientific Group. Report of the WHO Scientific Group. Research on the Menopause in the 1990's: A. Geneva, 1996, pp. 866:861-879.